ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2009

Nov 12, 2009

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2009-09-30

Reporting Person: STEWART R BRUCE (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-05-20	Common Stock	G	200000	$0.61	Disposed	511500	Direct